PE firm Somerset Indus closes $288 million Fund III, beats target
Benchmarks Nifty22,888.95-257.21FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.8 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.64 % Invest NowEnter search…

Somerset Indus Capital Partners closed its third fund at $288 million, exceeding targets, to invest in affordable healthcare across India. Focus areas include delivery, pharma, diagnostics and medtech, targeting underserved tier I and II cities with scalable, impact-driven platforms.
Healthcare-focused private equity firm Somerset Indus Capital Partners on Monday said it has closed fundraising for its third fund at close to $288 million, exceeding its initial target of $250 million, with a focus on healthcare in tier I and tier II cities.The Mumbai-based fund will invest in businesses delivering affordable and accessible care across healthcare delivery, pharmaceuticals, medical devices, diagnostics and allied segments, the firm said in a release.
The latest round saw participation from development finance institutions, global investment firms, domestic financial institutions, insurance companies, funds of funds, family offices and impact investors across Europe, the United States and Southeast Asia.
“The successful fund raise is a strong endorsement of our strategy and execution capabilities,” said Avinash Kenkare, Partner, Somerset Indus Capital Partners.
The firm said strong participation from existing investors, alongside commitments from new marquee LPs, underscores continued confidence.
Live Events
“Fund III positions us to deepen our presence in underserved markets and partner with entrepreneurs building scalable healthcare platforms. We remain committed to delivering measurable impact alongside sustainable financial returns,” said Mayur Sirdesai, Partner, Somerset Indus Capital Partners.
Somerset typically invests between $15 million and $40 million per portfolio company and, through co-investment syndication with its limited partner (LP) network, can participate in larger transactions in the range of $60–80 million.
The additional capital will support opportunities in preventive care and outpatient department (OPD)-linked insurance, healthcare financing, embedded insurance solutions, value-driven generics, India-focused medical technology innovation and diagnostics platforms aimed at improving access beyond metro markets, the company said.
Through Fund III, Somerset has already made three investments, including Kerala-based medical equipment firm Cyrix Healthcare, pharmaceutical packaging company Printmann Offset and Bengaluru-based hospital chain NU Hospitals.
The firm said its earlier funds have delivered strong performance, with Fund I has returned four times the total capital contributed by the investors, while Fund II is progressing toward exits, with its first realisation completed in September 2025 at around four times return on total investment, said the company.
Founded in 2011, Somerset Indus Capital Partners manages assets of around $500 million across three funds.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our ETMarkets WhatsApp channel)
Read More News onsomerset indus capital partnershealthcare private equity indiafund iii fundraisinghealthcare investment indiaaffordable healthcare indiamedical devices investmentpharma sector indiadiagnostics market indiatier ii healthcare growthimpact investing india
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
...moreless(You can now subscribe to our ETMarkets WhatsApp channel)
Read More News onsomerset indus capital partnershealthcare private equity indiafund iii fundraisinghealthcare investment indiaaffordable healthcare indiamedical devices investmentpharma sector indiadiagnostics market indiatier ii healthcare growthimpact investing india
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
...morelessContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories& personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
in-depth stock reportsSubscribe NowET
Unlock Access to All Exclusives with ETPrime FREE TRIAL
15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers
Trial offer expiring in00 : 05 : 00
I'd rather pay ₹2599 nowUh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Prime Account Detected!
It seems like you're already an ETPrime member with
Login using your ET Prime credentials to enjoy all member benefits
Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.
Unlock ETPrime's Exclusive Stories Today!
Big Price Drop! Flat 40% Off
Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In nowOffer Exclusively For You
Save up to Rs. 700/-
ON ET PRIME MEMBERSHIP
Avail OfferOffer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail OfferOffer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail OfferOffer Exclusively For You
Get Flat 40% Off
Then ₹ 1749 for 1 year
Avail OfferOffer Exclusively For You
ET Prime at ₹ 49 for 1 month
Then ₹ 1749 for 1 year
Avail OfferSpecial Offer
Get flat 40% off on ETPrime
Avail OfferAvail OfferClaim NowAlready a Member? Sign In nowNeed Assistance?
Connect with an ETPrime expert for personalized support and guidance
+91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '' + h3 + '
' + h4 + '
- ' + listing + '
What’s Included with
ETPrime Membership
1Exclusive Insights That Matter
Uncover the truth with our investigative stories
Make strategic moves using the real-world case studies
Read industry-specific stories to identify emerging trends
Spot opportunities with in-depth insights that matter
Trump temper on H-1B visas is forcing Indians to do these things to stay put in US
What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.
Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?
The problem with lab grown diamonds
Why a falling rupee is a better option for the economy
A list of top 20 momentum stocks that have delivered massive returns in one year
2Invest Wisely With Smart Market Tools & Investment Ideas
Alpha Trade
Get daily trade ideas from SEBI-registered research analysts.
Investment Ideas
Grow your wealth with stock ideas & sectoral trends.
Stock Reports Plus
All-in-one stock research with Stock Score, peer comparison & key signals.
BigBull Portfolio
Get to know where the market bulls are investing to identify the right stocks.
Stock Analyzer
Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.
Market Mood
Analyze the market sentiments & identify the trend reversal for strategic decisions.
Stock Talk Live at 9 AM Daily
Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.
3Stay informed anytime, anywhere with ET ePaper
ePaper - Print View
Read the PDF version of ET newspaper. Download & access it offline anytime.
ePaper - Digital View
Read your daily newspaper in Digital View & get it delivered to your inbox everyday.
Wealth Edition
Manage your money efficiently with this weekly money management guide.
TOI ePaper
Read the PDF version of TOI newspaper. Download & access it offline anytime.
Deep Explainers
Explore the In-depth explanation of complex topics for everyday life decisions.
Health+ Stories
Get fitter with daily health insights committed to your well-being.
Personal Finance+ Stories
Manage your wealth better with in-depth insights & updates on finance.
5Enjoy Complimentary Subscriptions From Top Brands
Stream new documentaries from all across the world every day.
Stories you might be interested in
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



